Fin Posillipo S.p.A.
Italyfinposillipo.it
Overview
Fin Posillipo is a holding company controlled by the Petrone Family that manages a diversified portfolio of investments. Founded in 1989, it has a strategic, long-term vision focused on pharmaceuticals, biotech, clean energy, and also invests in private equity and venture capital funds. It also operates as a financial and commercial consulting company within the pharmaceutical and healthcare sector.
Portfolio Companies
4
Website
finposillipo.itInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BetaGlue Therapeutics | Dec 2024 | VC Round | Co-investor |
| Pierrel S.p.A. | Jul 2023 | Follow-on Offering | Co-investor |
| BetaGlue Therapeutics | Jul 2022 | VC Round | Co-investor |
| 1000Farmacie | Apr 2020 | Seed | Co-investor |
| Altheia Science | Dec 2018 | Series A | Co-investor |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
